Efficacy of lidocaine spray in pain reduction during colposcopy-directed cervical biopsy: a randomized controlled trial

Not Applicable

Completed

• Conditions: Women with abnormal cervical cytology (ASC- US, ASC- H, LSIL); Lidocaine spray; Colposcopic directed biopsy; Cervical cancer; Pain score

• Registration Number: TCTR20171208001
• Lead Sponsor: o

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2017-12-08
• Study Completion: 2018-11-30
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Completed
• Sex: Female
• Target Recruitment: 360

Inclusion Criteria

Women with abnormal cervical screening test results and abnormal colposcopic findings that required a colposcopic directed biopsy.

Exclusion Criteria

1.Known history of hypersensitivity to lidocaine or to other components of the solution
2.Pregnancy
3.Post-hysterectomy
4.Bleeding disorders
5.Drug abuse
6.Cervical and vaginal infection
7.Inability to communicate in Thai.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Biopsy pain score. 2 minutes after apply 10% Lidocaine spray Visual analog scale

Secondary Outcome Measures

Name	Time	Method
/A N/A N/A